HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trialCharles M. Perou, Ana Vivancos, Fara Brasó‐Maristany et al.|UNC Libraries|2024Cited by 0